FDA D.I.S.C.O. Burst Edition: FDA approval of Fruzaqla (fruquintinib) for adult patients with metastatic colorectal cancer
0:00
3:30
FDA D.I.S.C.O. Burst Edition: FDA approval of Fruzaqla (fruquintinib) for adult patients with metastatic colorectal cancer
Altri episodi di "FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)"
Non perdere nemmeno un episodio di “FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)”. Iscriviti all'app gratuita GetPodcast.